Cefuroxime Plus cefuroxime axetil vs cefoperazone in treatment of lower respiratory tract infections
Hou Ji
Abstract
Hou Ji
Abstract
A randomized controlled clinical trial on cefuroxime plus cefuroxime axetil compared with cefoperazone was conducted for the treatment of lower respiratory tract infections.Thirty-four patients(M 27,F 7;age 53±s16a)were treated with cefuroxime 750mg,iv,gtt,tid for 5 d, followed by cefuroxime axetil 500 mg po, bid for 5 d.Another 34 patients (M18,F 16;age 55±14a)were treated with cefoperazone 1 g iv,gtt,tid for 10 d.Efficacy rates of the two groups were 97% and 94%,respectively,the bacterial clearance rates were 97% and 94% respectively,both P0.05.Adverse reaction rates were 3% and 6%,respectively.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
A randomized controlled clinical trial on cefuroxime plus cefuroxime axetil compared with cefoperazone was conducted for the treatment of lower respiratory tract infections.Thirty-four patients(M 27,F 7;age 53±s16a)were treated with cefuroxime 750mg,iv,gtt,tid for 5 d, followed by cefuroxime axetil 500 mg po, bid for 5 d.Another 34 patients (M18,F 16;age 55±14a)were treated with cefoperazone 1 g iv,gtt,tid for 10 d.Efficacy rates of the two groups were 97% and 94%,respectively,the bacterial clearance rates were 97% and 94% respectively,both P0.05.Adverse reaction rates were 3% and 6%,respectively.
Key concepts: Cefuroxime, Cefoperazone, Medicine, Adverse effect, Internal medicine, Respiratory tract infections, Respiratory tract, Gastroenterology